{
    "Pipeline Outcome": "Sufficient reads mapped to M. tuberculosis (H37Rv v3) for genome assembly, resistance prediction and relatedness assessment.",
    "Organism Identification": {
        "Human Reads": null,
        "Unclassified Reads": 106,
        "Non-Mycobacterium Bacteria Reads": 1916,
        "Mycobacterium Reads": 2800938
    },
    "Mycobacterium Results": {
        "Summary": [
            {
                "Name": "M. tuberculosis (lineage 3)",
                "Num Reads": 2754110,
                "Coverage": 99.6566,
                "Depth": 127.44500000000001
            }
        ],
        "Species": [
            {
                "Name": "M.tuberculosis",
                "Num Reads": 2754110,
                "Coverage": 99.6566,
                "Mean Depth": 127.44500000000001,
                "Length": 4411532
            }
        ],
        "Phylogenic Group": [
            {
                "Name": "Mycobacterium_tuberculosis_complex",
                "Coverage": 99.313,
                "Median Depth": 119
            }
        ],
        "Subspecies": [
            {
                "Name": "Mycobacterium_tuberculosis",
                "Coverage": 67.244,
                "Median Depth": 111
            }
        ],
        "Lineage": [
            {
                "Name": "lineage3",
                "Coverage": 100,
                "Median Depth": 128
            }
        ]
    },
    "Genomes": [
        {
            "Name": "M. tuberculosis",
            "Sequencing Quality": {
                "Mapped To": "M. tuberculosis (H37Rv v3) NC_000962.3",
                "Num Reads": 2754110,
                "Coverage": 99.4096,
                "Mean Depth": 127.44500000000001,
                "Mixed calls": 328,
                "Null calls": 26047,
                "Reference genome length": 4411532
            },
            "Resistance Prediction": {
                "Resistance Prediction Summary": {
                    "First-line treatment": {
                        "Isoniazid (INH)": "S",
                        "Rifampicin (RIF)": "S",
                        "Pyrazinamide (PZA)": "S",
                        "Ethambutol (EMB)": "S"
                    },
                    "Second-line treatment": {
                        "Moxifloxacin (MXF)": "U",
                        "Levofloxacin (LEV)": "S",
                        "Linezolid (LZD)": "S",
                        "Bedaquiline (BDQ)": "S"
                    },
                    "Reserve treatment": {
                        "Amikacin (AMI)": "S",
                        "Kanamycin (KAN)": "S",
                        "Streptomycin (STM)": "S",
                        "Capreomycin (CAP)": "S",
                        "Ethionamide (ETH)": "S",
                        "Delamanid (DLM)": "R",
                        "Clofazimine (CFZ)": "S"
                    }
                },
                "Resistance Prediction Detail": [
                    {
                        "Drug Name": "DLM",
                        "Mutations": [
                            {
                                "Gene": "fbiC",
                                "Mutation": "2565_del_ggcctag",
                                "Position": 2565,
                                "Ref": "",
                                "Alt": "",
                                "Coverage": [
                                    0,
                                    40
                                ],
                                "Prediction": "R",
                                "Evidence": {
                                    "Observed_samples": {
                                        "Present_SOLO_SR": 4,
                                        "Present_SOLO_R": 0,
                                        "Present_SOLO_S": 4
                                    },
                                    "Additional grading criteria applied": "Selection evidence",
                                    "FINAL CONFIDENCE GRADING": "2) Assoc w R - Interim",
                                    "INITIAL CONFIDENCE GRADING": "3) Uncertain significance",
                                    "WHO HGVS": "fbiC_LoF"
                                }
                            }
                        ]
                    },
                    {
                        "Drug Name": "MXF",
                        "Mutations": [
                            {
                                "Gene": "gyrA",
                                "Mutation": "R252L",
                                "Position": 252,
                                "Ref": "cga",
                                "Alt": "cta",
                                "Coverage": [
                                    0,
                                    126
                                ],
                                "Prediction": "U",
                                "Evidence": {
                                    "reporting_rule": "True"
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "Metadata": {
        "Pipeline build": "97c97e3",
        "Reference Data Files": {
            "manifest": "manifest_20231001",
            "species_list": "species_list_manifest_20250324.csv",
            "name_mapping": "competitive_mapping_mykrobe_names_20241105.csv",
            "ref_files": "Ref_prepare",
            "tb_ref_genome": "NC_000962.3.gbk",
            "tb_amr_cat": "NC_000962.3_WHO-UCN-TB-2023.5_v2.1_GARC1_RFUS.csv",
            "sundial_ref": "h37rv_20231215.fa.gz"
        }
    }
}